Source link : https://newshealth.biz/health-news/mavacamten-showing-real-world-success-in-treating-ohcm/
MANCHESTER — Mavacamten (Camzyos, Bristol Myers Squibb) continues to show promising results in patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), a consultant cardiologist said at the recent British Cardiovascular Society Annual Conference 2025. William Jenkins, a consultant cardiologist at the Royal Infirmary of Edinburgh, said that real world outcomes mirror those from clinical trials, including EXPLORER […]
The post Mavacamten Showing Real-World Success in Treating oHCM first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-10 17:41:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8